ConductScience.org, home

Paper40565795

Treating IgA Nephropathy: Looking at the Future Without Forgetting the Past.

Coppo R. J Clin Med, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Treating IgA Nephropathy: Looking at the Future Without Forgetting the Past. Papers, record 40565795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40565795

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treating IgA Nephropathy: Looking at the Future Without Forgetting the Past.
PubMed
Journal
J Clin Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-06-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Coppo RRosannahttps://orcid.org/0000-0003-4713-6282

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140082161IgAN Across the Age Spectrum: The Pediatric Perspective.Semin Nephrol2024https://conductscience.org/library/papers/40082161PubMed
232450154After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.Kidney Int2020https://conductscience.org/library/papers/32450154PubMed
336938094Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria.Kidney Int Rep2023https://conductscience.org/library/papers/36938094PubMed
428215945Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.Am J Kidney Dis2017https://conductscience.org/library/papers/28215945PubMed
528763548Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.JAMA2017https://conductscience.org/library/papers/28763548PubMed
634556300Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.Kidney Int2021https://conductscience.org/library/papers/34556300PubMed
74601708IgA nephropathy.Am J Pathol1974https://conductscience.org/library/papers/4601708PubMed
839369368The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort.J Nephrol2025https://conductscience.org/library/papers/39369368PubMed
937591292Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.Lancet2023https://conductscience.org/library/papers/37591292PubMed
1037914086Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.Kidney Int2024https://conductscience.org/library/papers/37914086PubMed
1138552841A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.Kidney Int2024https://conductscience.org/library/papers/38552841PubMed
1239455063Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.J Am Soc Nephrol2025https://conductscience.org/library/papers/39455063PubMed
1321949093The pathophysiology of IgA nephropathy.J Am Soc Nephrol2011https://conductscience.org/library/papers/21949093PubMed
1433123355Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy.Clin Kidney J2020https://conductscience.org/library/papers/33123355PubMed
1510093981Corticosteroids in IgA nephropathy: a randomised controlled trial.Lancet1999https://conductscience.org/library/papers/10093981PubMed
1617067945Normal structure, function, and histology of mucosa-associated lymphoid tissue.Toxicol Pathol2006https://conductscience.org/library/papers/17067945PubMed
1726986150Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.Medicine (Baltimore)2016https://conductscience.org/library/papers/26986150PubMed
1834642783The mucosal immune system and IgA nephropathy.Semin Immunopathol2021https://conductscience.org/library/papers/34642783PubMed
1937931634Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.Lancet2023https://conductscience.org/library/papers/37931634PubMed
2039460694Atrasentan in Patients with IgA Nephropathy.N Engl J Med2025https://conductscience.org/library/papers/39460694PubMed

See all 65 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42941618Association of the Red Blood Cell Distribution Width-to-Albumin Ratio with Renal Outcomes in Chinese Patients with IgA Nephropathy.J Clin Med2026https://conductscience.org/library/papers/42941618PubMed
42811306Targeted-release Budesonide (Nefecon) versus systemic glucocorticoids for IgA nephropathy: a placebo-anchored indirect treatment comparison of randomized controlled trials.BMC Nephrol2026https://conductscience.org/library/papers/42811306PubMed
42292268Effect of SGLT2 inhibitors on microscopic hematuria in IgA nephropathy: a review from the perspective of disease activity biomarkers.Front Med (Lausanne)2026https://conductscience.org/library/papers/42292268PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40565795

GET https://conductscience.org/api/papers/v1/40565795/references?page=2